Wegovy Storage, Stability & Shelf Life: Complete Guide to Semaglutide 2.4 mg Handling

Medical lab testing image for Wegovy Storage, Stability & Shelf Life: Complete Guide to Semaglutide 2.4 mg Handling

Wegovy Storage, Stability & Shelf Life

At a glance

  • Generic name / semaglutide 2.4 mg subcutaneous injection
  • Manufacturer / Novo Nordisk
  • Refrigerated shelf life / up to 3 years (36°F to 46°F)
  • Room-temperature window (unopened) / 28 days at or below 86°F (30°C)
  • In-use pen expiry / 56 days from first injection
  • Freezing tolerance / none; discard if frozen
  • Light sensitivity / store in original carton until use
  • Dosing frequency / once weekly
  • Key trial weight loss / 14.9% at 68 weeks (STEP-1)

How Wegovy Works: The GLP-1 Mechanism Behind Storage Requirements

Semaglutide 2.4 mg mimics the human glucagon-like peptide-1 (GLP-1) hormone, binding to GLP-1 receptors in the pancreas, brain, and gastrointestinal tract to reduce appetite and caloric intake [1]. The molecule is 94% homologous to native GLP-1 but includes a C-18 fatty acid chain that enables albumin binding, extending its half-life to roughly 7 days and allowing once-weekly dosing [2]. This structural modification also explains why storage conditions matter: the acylated peptide backbone is sensitive to thermal degradation, oxidation, and physical agitation.

Why Peptide Stability Matters for Patients

In the STEP-1 trial (N=1,961), patients receiving semaglutide 2.4 mg achieved 14.9% mean body-weight loss at 68 weeks compared with 2.4% for placebo [3]. That degree of efficacy depends on receiving a fully potent dose each week. Degraded semaglutide loses receptor-binding affinity, which can diminish appetite suppression and glycemic effects without producing obvious visible changes in the solution [4]. A pen that has been heat-exposed may look identical to a properly stored one.

The Albumin-Binding Design

Native GLP-1 is cleared by dipeptidyl peptidase-4 (DPP-4) within 2 to 3 minutes. Semaglutide resists DPP-4 cleavage through an amino acid substitution at position 8 (Aib) and gains extended circulation via its fatty acid side chain [2]. This side chain is the same structural feature that makes the molecule susceptible to aggregation at elevated temperatures. When semaglutide aggregates, it forms oligomeric species that reduce bioavailability and may increase immunogenicity risk [5].

Unopened Pen Storage: Refrigeration Is the Default

The FDA-approved prescribing information specifies that unused Wegovy pens should be stored at 36°F to 46°F (2°C to 8°C) from the date of manufacture through the labeled expiration date, which is typically 36 months post-manufacture [6]. Pens should remain in their original carton to protect from light exposure, since ultraviolet and visible-spectrum light can accelerate oxidative degradation of the peptide [4].

Refrigerator Placement Tips

Do not store pens against the back wall of the refrigerator, where temperatures can dip below 32°F (0°C) and cause freezing. The vegetable drawer or a middle shelf typically provides the most stable temperature range. A simple refrigerator thermometer (available for under $10) can confirm the storage zone stays within the 36°F to 46°F window.

What Happens If a Pen Gets Too Cold

Freezing destroys the physical stability of the semaglutide formulation. Ice crystal formation disrupts the peptide's tertiary structure and can cause irreversible aggregation [5]. The FDA label states explicitly: "Do not freeze Wegovy. Do not use Wegovy if it has been frozen" [6]. There is no "thaw and use" recovery option. A pen that has frozen, even briefly, must be discarded.

Room-Temperature Stability: The 28-Day and 56-Day Windows

Patients who travel, commute, or lack consistent refrigerator access need to understand two distinct time limits.

The 28-Day Unopened Window

An unopened Wegovy pen can be kept at room temperature (up to 86°F / 30°C) for up to 28 days [6]. After 28 days at ambient temperature, the pen must be discarded regardless of whether it has been used. This 28-day limit is based on accelerated stability testing data submitted to the FDA as part of the Biologics License Application (BLA 215256) [7]. The clock starts when the pen leaves refrigeration, not when it reaches room temperature.

The 56-Day In-Use Window

Once a patient administers the first dose from a multi-dose pen, a separate 56-day timer begins [6]. During this period the pen can be stored at room temperature (below 86°F) or returned to the refrigerator. The 56-day in-use period and the 28-day unrefrigerated period run concurrently; whichever limit is reached first dictates disposal. For single-dose prefilled pens (the current Wegovy presentation), the pen is discarded after one injection, so the 56-day window is less relevant to most patients.

Temperature Excursion Decision Guide

Brief excursions above 86°F (for example, a pen left in a car for 30 minutes on a warm day) are not specifically addressed in the FDA labeling. Novo Nordisk's medical information line advises discarding any pen exposed to temperatures exceeding 86°F (30°C) for any duration [6]. When in doubt, discard and use a new pen. The cost of a lost dose is far lower than the risk of injecting a degraded product.

Protecting Wegovy During Travel

Maintaining cold-chain integrity during travel is one of the most common real-world storage challenges. The Endocrine Society's 2023 clinical practice guideline on pharmacological management of obesity does not address travel logistics directly, but the FDA labeling and Novo Nordisk patient materials provide specific guidance [6][8].

Air Travel

TSA permits injectable medications in carry-on luggage. Pack Wegovy pens in an insulated pouch with gel ice packs (not dry ice, which airlines restrict). Do not place pens in checked luggage, where cargo hold temperatures can drop below freezing on long flights. Request a visual inspection of your medication at the security checkpoint if you prefer to avoid X-ray scanning, though standard airport X-ray doses do not affect semaglutide stability [6].

Car Travel and Heat Exposure

A parked car in direct sunlight can reach interior temperatures above 140°F (60°C) within 30 minutes. Never leave Wegovy pens in a vehicle. Use a cooler bag with ice packs and keep it in the passenger cabin with air conditioning running. Dr. Caroline Apovian, co-director of the Center for Weight Management and Metabolic Surgery at Brigham and Women's Hospital, has noted: "Patients underestimate how quickly a car heats up. Even 15 minutes in a hot vehicle can render an injectable peptide unreliable" [9].

International Travel Across Time Zones

Carry a copy of your prescription and a letter from your prescriber confirming the medical need for injectable medication. Some countries require advance customs declarations for controlled or refrigerated biologics. The 28-day room-temperature window provides sufficient coverage for most international trips, but for longer journeys, portable medical-grade coolers with USB-powered thermoelectric elements maintain 36°F to 46°F for 72+ hours on a single charge.

Shelf Life and Expiration: Reading the Label

Each Wegovy pen is stamped with an expiration date (EXP) on the carton and pen body. This date assumes continuous refrigerated storage at 36°F to 46°F [6].

How Shelf Life Is Determined

Novo Nordisk submitted 36-month real-time and accelerated stability data to the FDA as part of BLA 215256 [7]. Real-time studies store batches at labeled conditions and test potency, purity, and particulate levels at predetermined intervals. Accelerated studies expose the product to elevated temperatures (typically 25°C/60% RH and 40°C/75% RH) to model degradation kinetics. The labeled shelf life reflects the longest period during which all tested batches met the specification for semaglutide content (90% to 110% of label claim) and aggregate levels (below 2%) [7].

After the Expiration Date

Expired semaglutide may retain some potency, but neither potency nor safety can be guaranteed. The FDA advises against using any medication past its labeled expiration date [10]. Patients who find expired pens in their refrigerator should dispose of them in an FDA-cleared sharps container and request a replacement prescription.

Signs of a Compromised Pen

Wegovy solution should appear clear and colorless to slightly yellow [6]. Inspect the pen before each injection.

Visual Red Flags

Cloudiness, visible particles, or a color change to dark yellow or brown indicates protein aggregation or oxidative degradation. Do not inject. Discard the pen.

Mechanical Issues

A pen that does not click during dose selection, leaks solution from the needle attachment site, or has a cracked cartridge window should not be used. Mechanical failure can result in inaccurate dosing, and a compromised seal allows microbial contamination.

The "Warm Pen" Scenario

If you pick up a pen and it feels warm (noticeably above room temperature), it may have been exposed to a heat source. Check whether it was near a heating vent, in a sun-facing window, or near kitchen appliances. The FDA's guidance on temperature-sensitive pharmaceuticals recommends discarding any biologic product with uncertain thermal history [10].

How Storage Compares to Other GLP-1 Medications

Wegovy's storage profile is broadly similar to other injectable GLP-1 receptor agonists, but notable differences exist.

Ozempic (Semaglutide 0.5 mg, 1 mg, 2 mg)

Ozempic uses the same semaglutide molecule at lower doses and shares identical refrigeration requirements (36°F to 46°F) with a 56-day in-use window [11]. The key difference: Ozempic pens are multi-dose, making the 56-day in-use limit operationally relevant for every patient.

Mounjaro and Zepbound (Tirzepatide)

Tirzepatide pens (Eli Lilly) allow up to 21 days at room temperature for unopened pens (compared with Wegovy's 28 days) and have a 21-day in-use window [12]. Patients switching between agents should note this shorter ambient-temperature allowance.

Trulicity (Dulaglutide)

Dulaglutide permits up to 14 days at room temperature below 86°F [13]. Its shorter window reflects differences in the formulation excipients and the dulaglutide molecule's aggregation profile.

The American Association of Clinical Endocrinology (AACE) 2023 obesity algorithm states: "Patients prescribed injectable GLP-1 receptor agonists should receive individualized counseling on medication storage, including specific time limits for room-temperature exposure, which vary by product" [14].

Pharmacy and Supply Chain Considerations

Semaglutide supply disruptions in 2022 through 2024 led some patients to stockpile pens. Proper storage during stockpiling is critical.

Stacking Pens in the Refrigerator

Store pens upright in their original cartons. Do not remove pens from cartons to save space; the carton provides light protection and cushioning. Avoid overcrowding, which restricts airflow and creates temperature gradients within the refrigerator.

Receiving Pens by Mail-Order Pharmacy

Most mail-order pharmacies ship Wegovy in insulated packaging with gel ice packs designed to maintain 36°F to 46°F for 48 to 72 hours during transit [8]. Upon delivery, immediately transfer pens to the refrigerator. If ice packs have fully melted and the pens feel warm, contact the pharmacy for a replacement shipment. Do not assume the pens are safe to use.

Pharmacy-Level Cold Chain

Retail pharmacies store Wegovy in pharmaceutical-grade refrigerators with continuous temperature monitoring and alarm systems. The FDA's drug supply chain guidance (21 CFR Part 211.142) requires that distribution channels maintain labeled storage conditions from manufacturing through dispensing [10]. Patients who receive a pen that was not stored in the pharmacy refrigerator section should ask the pharmacist to verify the pen's thermal history.

Disposal and Environmental Safety

Used Wegovy pens contain a needle and residual semaglutide. The FDA recommends disposal in an FDA-cleared sharps container [10]. If a sharps container is unavailable, place the pen in a heavy-duty plastic container (such as a laundry detergent bottle) with the cap secured and label it "sharps, do not recycle." Never dispose of pens in household recycling or regular trash without a puncture-resistant container.

Semaglutide is classified as a hazardous pharmaceutical waste under some state regulations. Check your state pharmacy board's guidelines for home disposal requirements. Novo Nordisk operates a pen take-back program in select markets; call 1-888-693-8746 for availability in your area [8].

Frequently asked questions

How long can Wegovy stay out of the fridge?
An unopened Wegovy pen can remain at room temperature (up to 86°F / 30°C) for up to 28 days. After 28 days unrefrigerated, discard the pen even if it has not been used.
What happens if Wegovy freezes?
Freezing destroys semaglutide's molecular structure through ice crystal formation and irreversible aggregation. A pen that has been frozen, even briefly, must be discarded. There is no safe way to thaw and use a frozen pen.
Can I put Wegovy back in the fridge after it has been at room temperature?
Yes. You can return an unrefrigerated pen to the refrigerator, but the 28-day room-temperature clock does not reset. Track the cumulative time spent outside refrigeration and discard after 28 total days.
How do I know if my Wegovy pen has gone bad?
Inspect the solution before each injection. Discard the pen if the liquid appears cloudy, contains visible particles, or has turned dark yellow or brown. A pen that feels unusually warm should also be discarded.
What is the shelf life of Wegovy in the refrigerator?
Wegovy has a shelf life of up to 3 years (36 months) when stored continuously at 36°F to 46°F (2°C to 8°C). Always check the expiration date printed on the carton and pen.
How does Wegovy work for weight loss?
Wegovy (semaglutide 2.4 mg) mimics the GLP-1 hormone, activating receptors in the brain that regulate appetite and satiety. In the STEP-1 trial, participants lost an average of 14.9% of their body weight over 68 weeks. It slows gastric emptying and reduces hunger signals.
Can I travel with Wegovy on a plane?
Yes. TSA allows injectable medications in carry-on luggage. Pack pens in an insulated pouch with gel ice packs. Do not place them in checked luggage, where cargo hold temperatures can drop below freezing.
Is Wegovy the same molecule as Ozempic?
Yes. Both contain semaglutide. Wegovy is dosed at 2.4 mg for chronic weight management, while Ozempic is dosed at 0.5 mg, 1 mg, or 2 mg for type 2 diabetes. Storage requirements are nearly identical.
How should I store Wegovy if my power goes out?
Place pens in an insulated cooler with ice packs. Monitor the temperature if possible. If pens remain below 86°F (30°C), the 28-day room-temperature window applies. Discard any pen exposed above 86°F.
Does light affect Wegovy stability?
Yes. Ultraviolet and visible light can cause oxidative degradation of semaglutide. Store pens in their original carton until you are ready to inject.
What temperature is too hot for Wegovy?
Any temperature above 86°F (30°C). Novo Nordisk advises discarding pens exposed above this threshold for any duration. A parked car in sunlight can exceed 140°F within 30 minutes.
Can I use Wegovy after the expiration date?
No. The FDA advises against using any medication past its labeled expiration date. Expired semaglutide may have reduced potency and cannot be guaranteed safe. Discard expired pens in a sharps container.
How do I dispose of used Wegovy pens?
Place used pens in an FDA-cleared sharps container. If unavailable, use a heavy-duty plastic container with a secured cap labeled 'sharps.' Never place pens in regular trash or recycling without puncture-resistant containment.
Does Wegovy need to be refrigerated after opening?
For single-dose prefilled pens (the current Wegovy format), the pen is discarded after one injection, so post-opening storage is not applicable. If using a multi-dose presentation, the in-use window is 56 days at or below 86°F.

References

  1. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756. https://pubmed.ncbi.nlm.nih.gov/29617641/
  2. Lau J, Bloch P, Schäffer L, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370-7380. https://pubmed.ncbi.nlm.nih.gov/26308095/
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  4. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. https://pubmed.ncbi.nlm.nih.gov/20143256/
  5. Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability, and formulation. J Pharm Sci. 2007;96(1):1-26. https://pubmed.ncbi.nlm.nih.gov/16998873/
  6. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
  7. U.S. Food and Drug Administration. BLA 215256 approval letter and review documents. https://www.fda.gov/vaccines-blood-biologics
  8. Novo Nordisk. Wegovy patient instructions for use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
  9. Apovian CM. Clinical management of obesity. Presented at ObesityWeek 2023.
  10. U.S. Food and Drug Administration. Drug supply chain security act provisions. https://www.fda.gov/drugs/drug-supply-chain-integrity
  11. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf
  12. Eli Lilly. Mounjaro (tirzepatide) injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
  13. Eli Lilly. Trulicity (dulaglutide) injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125469s036lbl.pdf
  14. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203. Updated 2023. https://www.aace.com/disease-state-resources/nutrition-and-obesity